February 25, 2016 Exosomal Tau Blood Test May Detect CTE in the Living Researchers may have uncovered a way to detect chronic traumatic encephalopathy (CTE) in living individuals with a blood test that detects plasma exosomal tau. The preliminary results were published in the Journal of Alzheimer’s Disease. A definitive diagnosis of CTE has previously […]

by

February 17, 2016 Patients On HRT See Stroke Risk Increase with Migraine Severity LOS ANGELES — Women on hormone replacement therapy (HRT) who experience an increase in migraine severity of one grade or more are at increased risk for ischemic stroke, according to study results presented here at the 2016 International Stroke Conference. “We found […]

by

Cannabis oil, prescribed to Greta Botker, 7, sits on the kitchen counter top of her parent‚’s Colorado home Feb. 6, 2014. The cannabis oil is extracted from a genetically modified strain of marijuana called Charlotte‚’s Web which produces a low THC (tetrahydrocannabinol) yield and high CDB (Cannabidiol) yield.(Photo: USA Today) MUNCIE — State Rep. Sue Errington, […]

by

LOS ANGELES, CA — (Marketwired) — 02/24/16 — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is proud to announce Purple Haze Properties LLC www.purplehazeproperties.com, created by Andrew Pitsicalis and Leon Hendrix, have partnered with Cannabis Science to create Jimi Hendrix… read more at: http://news.sys-con.com/node/3694037

by

COSTA MESA, CA — (Marketwired) — 03/17/16 — Sipp Industries, Inc. (OTC: SIPC), a diversified conglomerate corporation specializing in technology, manufacturing and distribution of commercial and consumer products announces the launch of hemp products for the equestrian market. Operating under its wholly owned subsidiary, Major Hemp, the Company will market organic cold-pressed hemp oil, hemp […]

by

By Paul Armentano, NORML Deputy Director Preclinical study data published online in the scientific journal Nutrition Diabetes reports that tetrahydrocannabivarin (THCV) — a naturally occurring analogue of THC — possesses positive metabolic effects in animal models of obesity. British researchers assessed the effects of THCV administration on dietary-induced and genetically modified obese mice. Authors reported that although THCV administration did not […]

by

According to a new study, a non-psychotropic component of marijuana called Cannabidiol may enhance the healing process of bone fissures. The study also found that bones treated with marijuana were stronger and less likely to fracture again In the wake of moves to legalize marijuana for medicinal purposes across many states, researchers are now digging […]

by

A cannabis derivative could help children with epilepsy, according to a series of studies presented at the American Epilepsy Society’s 69th Annual Meeting in Philadelphia, PA. A cannabis derivative appears to help prevent seizures. Cannabidiol (CBD), a type of cannabinoid, has come into focus as a potential therapy for various conditions, including epilepsy. CBD is […]

by

Erythropoietin (EPO) support during radiation therapy had no impact on outcomes in patients with head and neck squamous-cell carcinoma (HNSCC) and mild or moderate anemia, long-term results of a randomized trial showed. Locoregional failure, locoregional progression-free survival (PFS), and overall survival (OS) did not differ significantly between patients who received concomitant EPO and those who […]

by

March 14, 2016 Cannabidiol Therapy Reduces Seizure Frequency in Dravet Syndrome Investigators have announced positive results for the first phase 3 clinical trial of GW Pharmaceutical’s cannabidiol therapy Epidiolex in patients with Dravet syndrome. The unpublished results mark a milestone for Epidiolex, which has already received Orphan Drug Designation and Fast Track Designation from the […]

by

WASHINGTON, March 14 (UPI) — The marijuana-based drug Epidiolex significantly reduced seizures in children with Dravet syndrome in a phase 3 clinical trial, lending scientific credence to a treatment used for several years but mostly supported by anecdotal evidence. GW Pharmaceuticals, which developed the drug, announced the results of the first of four trials with […]

by